glp 1 patch how does it work What is a GLP-1 Patch? GLP-1 Weight Loss Patches |
Description
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey

Kim HJ, Kang TU, Kim MJ, Swan H, Park SM

Specific legislation may require us to retain certain data for a longer or shorter period

doi: 10.1016/S2213-8587(14)70120-2

The company maintains the largest market share and extensive clinical trial data supporting efficacy and safety profiles across diverse patient populations

Supply challenges have affected GLP-1 medications in recent years, with significant shortages of semaglutide products driven by increased global demand
